Rockefeller Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
Other funds holding CLVS
Rockefeller Capital Management's CLVS Position: Q1 2023 in Review
Rockefeller Capital Management sold out of Clovis Oncology, Inc. (CLVS) in Q1 2023, closing a stake of 375 shares.
Rockefeller Capital Management first reported a position in CLVS in Q4 2019 and held it in 13 quarters. The position peaked at $103K in Q2 2021. 2 funds tracked by Wall St. Rank hold CLVS as of Q1 2023.
- Rockefeller Capital Management reported no remaining Clovis Oncology, Inc. position as of Q1 2023 after selling out during the quarter.
- Rockefeller Capital Management sold 375 Clovis Oncology, Inc. shares in Q1 2023.
- Rockefeller Capital Management first reported a position in Clovis Oncology, Inc. in Q4 2019 and held it in 13 quarters.
- Rockefeller Capital Management's Clovis Oncology, Inc. position peaked at $103K in Q2 2021.
- 2 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2023.
Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.